Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-25 4:30 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Theofilos Charles Steve | 2,506,321 5.900% | 2,506,321 (New Position) | View |
| 2024-10-25 4:28 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Patel Samir Rashmikant | 2,466,377 5.800% | 2,466,377 (New Position) | View |
| 2024-10-25 4:26 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | KP Biotech Group LLC | 2,572,582 6.100% | 2,572,582 (New Position) | View |
| 2024-10-25 4:23 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | CA Patel F&F Investments LLC | 2,572,582 6.100% | 2,572,582 (New Position) | View |
| 2024-10-25 4:20 pm Purchase | 13D | Kintara Therapeutics Inc. KTRA | Patel Vijay | 12,346,430 26.700% | 12,346,430 (New Position) | View |
| 2024-10-25 4:16 pm Purchase | 13D | Kintara Therapeutics Inc. KTRA | Bianco James A. | 2,704,901 6.400% | 2,704,901 (New Position) | View |
| 2023-02-13 4:29 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Lind Global Fund II LP | 75,472 0.100% | 75,472 (New Position) | View |
| 2022-04-20 5:11 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Lind Global Fund II LP | 3,773,586 5.800% | 3,773,586 (New Position) | View |
| 2022-02-07 1:26 pm Sale | 13G | Kintara Therapeutics Inc. KTRA | Pilkiewicz Carolyn | 1,170,290 2.410% | -562,499 (-32.46%) | View |
| 2021-02-08 3:18 pm Sale | 13G | Kintara Therapeutics Inc. KTRA | Pilkiewicz Carolyn | 1,732,789 7.030% | -525,000 (-23.25%) | View |
| 2021-01-29 07:00 am Purchase | 13G | Kintara Therapeutics Inc. KTRA | INTRACOASTAL CAPITAL LLC | 900,125 3.500% | 900,125 (New Position) | View |
| 2020-11-16 2:37 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Pilkiewicz Carolyn | 2,257,789 9.150% | 2,257,789 (New Position) | View |
| 2020-08-28 4:05 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | STERN ADAM K | 1,653,970 6.950% | 1,653,970 (New Position) | View |
| 2020-02-14 3:56 pm Sale | 13G | Kintara Therapeutics Inc. KTRA | Anson Funds Management LP | 290,125 1.500% | -4,875 (-1.65%) | View |
| 2020-02-11 06:19 am Sale | 13G | Kintara Therapeutics Inc. KTRA | INTRACOASTAL CAPITAL LLC | 700,000 5.800% | -208,021 (-22.91%) | View |
| 2020-02-10 3:16 pm Sale | 13G | Kintara Therapeutics Inc. KTRA | CVI Investments Inc. | 599,131 4.900% | -75,869 (-11.24%) | View |
| 2020-01-23 3:10 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Empery Asset Management LP | 1,440,125 4.990% | 1,147,625 (+392.35%) | View |
| 2020-01-21 12:17 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | SABBY MANAGEMENT LLC | 568,845 11.000% | 568,845 (New Position) | View |